Trial intelligence / Profile preview

Optimal effective volume of lidocaine for infraorbital nerve block in trigeminal neuralgia

ChiCTR2500105596Phase 2Recruiting

Sponsor
Pain Department of Nanjing Drum Tower Hospital
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of lidocaine in trigeminal neuralgia (TN), sponsored by Pain Department of Nanjing Drum Tower Hospital. Primary endpoint: Sensation (cold, tactile). Started Jul 2025; status: recruiting.

02

Drugs

lidocaine
03

Conditions

trigeminal neuralgia (TN)

Beyond the preview

Go deeper on ChiCTR2500105596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500105596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call